12 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MyShoulder Planner (5.3SSWPL)
FDA 510(k)
FDA Class 2
·Orthopedic
STRAIGHT IMPACTOR M6
FDA UDI
FOURNITURES HOSPITALIERES INDUSTRIE·03661489412929·
OsteoMed
FDA UDI
OSTEOMED LLC·00845694023016·FPS 2.7 NC Fusion Plate Large
OsteoMed
FDA UDI
OSTEOMED LLC·00845694077606·FPS 2.7 NC Fusion Large Plate Sterile Qty 2
TRAUS SIP20
FDA 510(k)
FDA Class 1
·Dental
Rightest Blood Glucose Monitoring System GM700, Rightest Blood Glucose Monitoring System GM650, GE200 Blood Glucose Monitoring System, and GE300 Talking Blood Glucose Monitoring System
FDA 510(k)
FDA Class 2
·Clinical Chemistry
IMP,TSV,4.7,16,MTX,MG
FDA Adverse Event
Injury
·ZIMMER DENTAL·Product code DZE·September 24, 2021
ANGIO-SEAL DEVICE
FDA Adverse Event
Injury
·ST. JUDE MEDICAL·Product code MGB·November 20, 2008
STENOSCOP
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·August 17, 2011
DIMENSION EXL WITH LM
FDA Adverse Event
Malfunction
·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Product code DHA·July 22, 2013
INSYTE AUTOGUARD YEL 24GA X 0.75IN
FDA Adverse Event
Malfunction
·BECTON DICKINSON·Product code FOZ·June 14, 2024
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014